Gradient Investments LLC cut its stake in shares of iShares Biotechnology ETF ( NASDAQ:IBB – Free Report ) by 49.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 433 shares of the financial services provider's stock after selling 418 shares during the period. Gradient Investments LLC's holdings in iShares Biotechnology ETF were worth $55,000 as of its most recent SEC filing. A number of other institutional investors have also made changes to their positions in IBB.

https://www.dailypolitical.com/2023/09/20/ishares-biotechnology-etf-nasdaqibb-shares-sold-by-gradient-investments-llc.html

#dailypolitical